praziquantel has been researched along with 4-phenyl-3-furoxancarbonitrile in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Cortese, D; Fruttero, R; Gasco, A; Guglielmo, S; Kommer, VP; Rolando, B; Vottero, F; Williams, DL | 1 |
| Attram, HD; Chibale, K; Dziwornu, GA; Gachuhi, S | 1 |
1 review(s) available for praziquantel and 4-phenyl-3-furoxancarbonitrile
| Article | Year |
|---|---|
Chemotherapy for human schistosomiasis: how far have we come? What's new? Where do we go from here?
Topics: | 2020 |
3 other study(ies) available for praziquantel and 4-phenyl-3-furoxancarbonitrile
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
New praziquantel derivatives containing NO-donor furoxans and related furazans as active agents against Schistosoma mansoni.
Topics: Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; Isoquinolines; Molecular Structure; Multienzyme Complexes; NADH, NADPH Oxidoreductases; Nitric Oxide; Nitric Oxide Donors; Oxadiazoles; Praziquantel; Pyrazines; Schistosoma mansoni; Structure-Activity Relationship | 2014 |